- Politics
- Diversity, equity and inclusion
- Financial Decision Making
- Telehealth
- Patient Experience
- Leadership
- Point of Care Tools
- Product Solutions
- Management
- Technology
- Healthcare Transformation
- Data + Technology
- Safer Hospitals
- Business
- Providers in Practice
- Mergers and Acquisitions
- AI & Data Analytics
- Cybersecurity
- Interoperability & EHRs
- Medical Devices
- Pop Health Tech
- Precision Medicine
- Virtual Care
- Health equity
HealthQuest Closes $440M Fund to Invest in Health-Tech Companies
HealthQuest is targeting innovative companies that create tech to drive better outcomes and reduce costs.
HealthQuest Capital today announced the close of its Fund III at $440 million that will be invested in companies delivering innovation across the healthcare industry to improve patient outcomes, enhance efficiency and reduce costs.
Fund III will target growth- and commercial-stage companies focused on medical technologies, diagnostics, digital health and innovative services.
“Technological innovations play a significant role in this transformation process — from improving patient care and safety, to driving down costs, reducing complexity and speeding delivery,” said Garheng Kong, M.D., Ph.D., MBA, HealthQuest’s founder and managing partner.
HealthQuest has assembled an advisory board that includes current and former CEOs and presidents from companies including Mayo Clinic, Johnson & Johnson, Humana and Medtronic.
The company leverages the experience of its advisors and partners to provide portfolio companies with guidance, expertise and a network of contacts across the industry.
Since its founding in 2013, the growth capital firm has more than $785 million in capital under management for companies fostering innovation across the healthcare spectrum. Its investments have resulted in four merger and acquisition transactions — Ajax Health, Avizia, Spirox and VirMedica.
HealthQuest looks for companies that are operating with capital-efficiency and an urgency to build a large and profitable enterprise. The company typically invests anywhere from $10 million to $30 million per company, with the ability to invest up to $50 million overtime. The capital is primary directed towards growing revenues and scaling the company.
“HealthQuest sees great opportunity to support growth and expansion for a wide array of commercial companies that are developing new solutions to optimize value across all sectors of healthcare,” Kong said.
Get the best insights in healthcare analytics directly to your inbox.
Related
Health Tech Kicks Off 2019 with $119M in Funding
5 Emerging Technologies that Will Change Healthcare
At $8B, Annual Digital Health Funding Has Already Surpassed 2017
Hospitals continue to struggle with IV fluid shortage, with some still delaying surgeries
November 25th 2024Some health systems have developed conservation strategies, and Baxter International has resumed production at its North Carolina plant. But some facilities are still facing serious challenges.
